Connection

Fabrice Carrat to Carcinoma, Hepatocellular

This is a "connection" page, showing publications Fabrice Carrat has written about Carcinoma, Hepatocellular.
Connection Strength

0.831
  1. Direct-acting antivirals and the risk of hepatocellular carcinoma: The end of a polemic? Liver Int. 2019 03; 39(3):446-447.
    View in: PubMed
    Score: 0.369
  2. Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study. Lancet. 2019 Apr 06; 393(10179):1453-1464.
    View in: PubMed
    Score: 0.368
  3. Time association between hepatitis C therapy and hepatocellular carcinoma emergence in cirrhosis: Relevance of non-characterized nodules - A response. J Hepatol. 2019 08; 71(2):446.
    View in: PubMed
    Score: 0.094
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.